Market Tracker

03/23 5:16pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

4.20
Delayed Data
As of 3:59pm ET
 +0.20 / +5.00%
Today’s Change
2.65
Today|||52-Week Range
7.60
+37.70%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close4.00
Today’s open4.03
Day’s range3.95 - 4.25
Volume460,952
Average volume (3 months)826,600
Market cap$283.5M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)-21.24%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc0.000.00%
VYGRVoyager Therapeutics...+0.52+4.76%
ADAPAdaptimmune Therapeu...-0.03-0.70%
ONVOOrganovo Holdings In...0.000.00%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts